LifeTec Group - Quarterly Report: Q2 2018
Lifetec news

LifeTec Group Quarterly Report: Q2 2018

Summer has arrived and the second quarter of the year has already come and gone. From a sun-drenched Netherlands, where it’s 27 degrees Celsius at the moment (80 to 84 Fahrenheit), now is a good time to look back on this second quarter of 2018: 

Sjoerd and Jurgen look back on TVT Chicago:
Lifetec news

Sjoerd and Jurgen look back on TVT Chicago:

We asked Sjoerd and Jurgen to share one memory that made TVT Chicago unforgettable for them:

LifeTec Group - Naudia Singh
Lifetec news

Introducing: Naudia Singh

Where would a fast-growing company like LifeTec Group be without an uber-quick, meticulous tower of strength in admin?

LifeTec Group - ASAIO 2018, Washington
Lifetec news

Promising Rookies present at ASAIO Washington

LifeTec Group’s Noemi Vanerio and Benjamin Kappler reported on their projects at the 64th ASAIO conference in Washington... >>>

Meet us in Chicago, at Transcatheter Valve Therapies (TVT)
Lifetec news

Meet us in Chicago, at Transcatheter Valve Therapies (TVT)

LifeTec Group will be in Chicago from 20 through 22 June to facilitate workshops and demos. They will involve Mitral Valve as well as Tricuspid Valve interventions, and various other subjects...

LifeTec Group - Mattia D'Alessi
Lifetec news

Introducing: Mattia D'Alessi

From Italy to Enschede and from Chicago via Italy to Eindhoven. Globetrotter Mattia D’Alessi has worked for LifeTec Group since January. And he feels like a fish in water here. 

"It feels a bit like they’re my Dutch family.” 

LifeTec Group - Bart Smeets
Lifetec news

Introducing: Bart Smeets

It’s his first full- time job, and it’s the job of his dreams: Bart Smeets (25) recently became an R&D engineer at LifeTec Group. He could not be prouder.

“I go to work every day feeling full of energy.” 

LifeTec Group - Blood Vessels in a box (alternative to animal testing)
Lifetec news

Blood Vessels -in-a-box-

“Towards the development of a pathological ex vivo blood vessel model": a possible alternative to ‘petri dishes’ as well as to animal testing. 

Vascular Bioreactor platform
Lifetec news

Coronary stent -in-a-box and -on-a-chip

Het Erasmus MC, de TU Delft en het Eindhovense medische technologiebedrijf LifeTec Group gaan nieuwe proefdiervrije modellen ontwikkelen die de menselijke vaatwand beter nabootsen. 

LifeTec Group - MedTech Quarterly - Q1 2018
Lifetec news

LifeTec Group Quarterly Report: Q1 2018

If the first quarter of 2018 is an indication for the other three to come, we are in for quite a year!


Get in touch

Please do not hesitate to contact LifeTec Group if you require any further information:


©2021 LifeTec Group.  Legal  Credits